{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:49:37Z","timestamp":1771062577193,"version":"3.50.1"},"reference-count":0,"publisher":"Wiley","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.clpt.2004.03.009","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T00:34:56Z","timestamp":1091666096000},"page":"104-112","source":"Crossref","is-referenced-by-count":90,"title":["Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states*1"],"prefix":"10.1111","volume":"76","author":[{"given":"K","family":"YU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","container-title":["Clinical Pharmacology & Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:14:57Z","timestamp":1699362897000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1016\/j.clpt.2004.03.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0009-9236(04)00131-6"],"URL":"https:\/\/doi.org\/10.1016\/j.clpt.2004.03.009","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}